Learn

Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that affects men as they age. It is the most common urological condition in men over 50, with up to 80% of men experiencing symptoms by the age of 80. In Australia, around 1 in 5 men aged 50 and over have been diagnosed with BPH.

The most common symptoms of BPH are difficulty urinating, a weak urine stream, and frequent urination, especially at night. There is no cure for BPH, but there are treatments available to help manage the symptoms. Minimally invasive techniques are used to treat BPH when medications are not effective or when the patient prefers a less invasive option, yet awareness of these options in low in general practitioners.

The education provides the GP with the required knowledge concerning when to consider minimally invasive treatment options, what these options are and how to access them. By increasing GP awareness of these treatment options, patients with BPH will have greater choice in how they wish to manage their condition.

Learning Outcomes

1. Describe minimally invasive treatment options for patients with severe Benign Prostatic Hyperplasia who are unsuitable for TURP
2. Outline a clinical approach to selection of patients who would be suitable for prostatic arterial emobolisation.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 48 hours to be reflected on your CPD Home Dashboard.